Coevolution of ticks and the vertebrate immune system has led to the development of immunosuppressive molecules that prevent immediate response of skin-resident immune cells to quickly fend off the parasite. In this article, we demonstrate that the tick-derived immunosuppressor sialostatin L restrains IL-9 production by mast cells, whereas degranulation and IL-6 expression are both unaffected. In addition, the expression of IL-1β and IRF4 is strongly reduced in the presence of sialostatin L. Correspondingly, IRF4- or IL-1R-deficient mast cells exhibit a strong impairment in IL-9 production, demonstrating the importance of IRF4 and IL-1 in the regulation of the Il9 locus in mast cells. Furthermore, IRF4 binds to the promoters of Il1b and Il9, suggesting that sialostatin L suppresses mast cell-derived IL-9 preferentially by inhibiting IRF4. In an experimental asthma model, mast cell-specific deficiency in IRF4 or administration of sialostatin L results in a strong reduction in asthma symptoms, demonstrating the immunosuppressive potency of tick-derived molecules.

3 Medical Clinic University Medical Center of the Johannes Gutenberg University Mainz 55131 Mainz Germany

Department of Pulmonology Leiden University Medical Center 2333 ZA Leiden the Netherlands

Faculty of Science University of South Bohemia 37005 České Budějovice Czech Republic

Institut für Medizinische Mikrobiologie und Krankenhaushygiene 35043 Marburg Germany

Institute for Immunology University Medical Center of the Johannes Gutenberg University Mainz 55131 Mainz Germany

Institute of Parasitology Biology Centre of the Academy of Sciences of the Czech Republic 37005 České Budějovice Czech Republic

Laboratory of Malaria and Vector Research National Institute of Allergy and Infectious Diseases National Institutes of Health Rockville MD 20852

Translational Oncology University Medical Center of the Johannes Gutenberg University 55131 Mainz Germany

000      

00000naa a2200000 a 4500

001      

bmc15031318

003      

CZ-PrNML

005      

20151013123921.0

007      

ta

008      

151005s2015 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.4049/jimmunol.1401823 $2 doi

035    __

$a (PubMed)26078269

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Klein, Matthias $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

245    10

$a Tick Salivary Sialostatin L Represses the Initiation of Immune Responses by Targeting IRF4-Dependent Transcription in Murine Mast Cells / $c M. Klein, TJ. Brühl, V. Staudt, S. Reuter, N. Grebe, B. Gerlitzki, M. Hoffmann, T. Bohn, A. Ulges, N. Stergiou, J. de Graaf, M. Löwer, C. Taube, M. Becker, T. Hain, S. Dietzen, M. Stassen, M. Huber, M. Lohoff, A. Campos Chagas, J. Andersen, J. Kotál, H. Langhansová, J. Kopecký, H. Schild, M. Kotsyfakis, E. Schmitt, T. Bopp,

520    9_

$a Coevolution of ticks and the vertebrate immune system has led to the development of immunosuppressive molecules that prevent immediate response of skin-resident immune cells to quickly fend off the parasite. In this article, we demonstrate that the tick-derived immunosuppressor sialostatin L restrains IL-9 production by mast cells, whereas degranulation and IL-6 expression are both unaffected. In addition, the expression of IL-1β and IRF4 is strongly reduced in the presence of sialostatin L. Correspondingly, IRF4- or IL-1R-deficient mast cells exhibit a strong impairment in IL-9 production, demonstrating the importance of IRF4 and IL-1 in the regulation of the Il9 locus in mast cells. Furthermore, IRF4 binds to the promoters of Il1b and Il9, suggesting that sialostatin L suppresses mast cell-derived IL-9 preferentially by inhibiting IRF4. In an experimental asthma model, mast cell-specific deficiency in IRF4 or administration of sialostatin L results in a strong reduction in asthma symptoms, demonstrating the immunosuppressive potency of tick-derived molecules.

650    _2

$a zvířata $7 D000818

650    _2

$a bronchiální astma $x genetika $x imunologie $x patologie $7 D001249

650    _2

$a vazebná místa $7 D001665

650    _2

$a degranulace buněk $x imunologie $7 D015550

650    _2

$a cystatiny $x imunologie $x farmakologie $7 D015891

650    _2

$a regulace genové exprese $7 D005786

650    _2

$a interakce hostitele a parazita $x imunologie $7 D006790

650    _2

$a přirozená imunita $x účinky léků $7 D007113

650    _2

$a imunosupresiva $x farmakologie $7 D007166

650    _2

$a interferonové regulační faktory $x nedostatek $x genetika $x imunologie $7 D050835

650    _2

$a interleukin-1beta $x genetika $x imunologie $7 D053583

650    _2

$a interleukin-6 $x genetika $x imunologie $7 D015850

650    _2

$a interleukin-9 $x antagonisté a inhibitory $x genetika $x imunologie $7 D016906

650    _2

$a mastocyty $x účinky léků $x imunologie $x patologie $7 D008407

650    _2

$a myši $7 D051379

650    _2

$a myši inbrední BALB C $7 D008807

650    _2

$a myši inbrední C57BL $7 D008810

650    _2

$a myši knockoutované $7 D018345

650    _2

$a promotorové oblasti (genetika) $7 D011401

650    _2

$a vazba proteinů $7 D011485

650    _2

$a receptory interleukinu-1 $x genetika $x imunologie $7 D017472

650    _2

$a signální transdukce $7 D015398

650    _2

$a genetická transkripce $7 D014158

655    _2

$a časopisecké články $7 D016428

655    _2

$a Research Support, N.I.H., Intramural $7 D052060

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Brühl, Till-Julius $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Staudt, Valérie $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Reuter, Sebastian $u III. Medical Clinic, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Grebe, Nadine $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Gerlitzki, Bastian $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Hoffmann, Markus $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Bohn, Toszka $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Ulges, Alexander $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Stergiou, Natascha $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a de Graaf, Jos $u Translational Oncology, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany;

700    1_

$a Löwer, Martin $u Translational Oncology, University Medical Center of the Johannes Gutenberg-University, 55131 Mainz, Germany;

700    1_

$a Taube, Christian $u Department of Pulmonology, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands;

700    1_

$a Becker, Marc $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Hain, Tobias $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Dietzen, Sarah $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Stassen, Michael $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Huber, Magdalena $u Institut für Medizinische Mikrobiologie und Krankenhaushygiene, 35043 Marburg, Germany;

700    1_

$a Lohoff, Michael $u Institut für Medizinische Mikrobiologie und Krankenhaushygiene, 35043 Marburg, Germany;

700    1_

$a Campos Chagas, Andrezza $u Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852;

700    1_

$a Andersen, John $u Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852; $7 gn_A_00006076

700    1_

$a Kotál, Jan $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, 37005 České Budějovice, Czech Republic; and.

700    1_

$a Langhansová, Helena $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, 37005 České Budějovice, Czech Republic; and Faculty of Science, University of South Bohemia, 37005 České Budějovice, Czech Republic.

700    1_

$a Kopecký, Jan $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, 37005 České Budějovice, Czech Republic; and Faculty of Science, University of South Bohemia, 37005 České Budějovice, Czech Republic.

700    1_

$a Schild, Hansjörg $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Kotsyfakis, Michalis $u Institute of Parasitology, Biology Centre of the Academy of Sciences of the Czech Republic, 37005 České Budějovice, Czech Republic; and.

700    1_

$a Schmitt, Edgar $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany;

700    1_

$a Bopp, Tobias $u Institute for Immunology, University Medical Center of the Johannes Gutenberg-University Mainz, 55131 Mainz, Germany; boppt@uni-mainz.de.

773    0_

$w MED00002741 $t Journal of immunology (Baltimore, Md. 1950) $x 1550-6606 $g Roč. 195, č. 2 (2015), s. 621-31

856    41

$u https://pubmed.ncbi.nlm.nih.gov/26078269 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20151005 $b ABA008

991    __

$a 20151013124110 $b ABA008

999    __

$a ok $b bmc $g 1092194 $s 914444

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2015 $b 195 $c 2 $d 621-31 $e 20150615 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741

LZP    __

$a Pubmed-20151005